A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
Recruiting · NCT05919680 · Registry updated 2025-01-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). | Intestinal Failure Associated Liver Disease | Recruiting | Phase 2 | 2025-01-07 | NCT05919680 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NorthSea Therapeutics B.V. | 1 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Duke University Medical Center | Durham | United States | 505 |
| Emory University School of Medicine | Atlanta | United States | 47 |
| Henry Ford Hospital | Detroit | United States | 326 |
| Mayo Clinic Rochester Campus | Rochester | United States | 1 |
| Mayo Clinic Scottsdale Campus | Scottsdale | United States | 2 |
| MedStar Georgetown University Hospital | Washington D.C. | United States | 204 |
| Mount Sinai Medical Center | New York | United States | 40 |
| The Cleveland Clinic | Cleveland | United States | 26 |
| The University of Chicago Medical Center | Chicago | United States | 33 |
| University of California San Francisco Medical Center | San Francisco | United States | 10 |
| University of Washington | Seattle | United States | 172 |
| Vanderbilt University School of Medicine | Nashville | United States | 3 |